Skip to main content
Nathan C. Dean

Nathan C. Dean, MD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine


Academic Office Information

Research Interests

  • Community-Acquired Infections
  • Outcome and Process Assessment (Health Care)
  • Severity of Illness Index
  • Pneumonia

Nathan C. Dean M.D. is Section Chief of Pulmonary and Critical Care Medicine at Intermountain Medical Center. He helped found the C. Duwayne Schmidt Chest Clinic in 2007 to provide outpatient pulmonary subspecialty care, as well as clinical research and teaching of residents and fellows. Dr Dean both teaches and provides direct patient care in the Schmidt Clinic at Intermountain Medical Center for patients with recurrent pneumonia, bronchiectasis, and chronic lung infections. He also attends in both the Shock Trauma and the Respiratory Intensive Care Units at Intermountain Medical Center, and on the pulmonary consult service.

Education History

Fellowship Cardiovascular Research Institute
University of California, San Francisco
Residency LDS Hospital
Stanford University School of Medicine
Undergraduate University of California, Berkeley

Selected Publications

Journal Article

  1. Irvin JA, Pareek A, Long J, Rajpurkar P, Eng DK, Khandwala N, Haug PJ, Jephson A, Conner KE, Gordon BH, Rodriguez F, Ng AY, Lungren MP, Dean NC (2021). CheXED: Comparison of a Deep Learning Model to a Clinical Decision Support System for Pneumonia in the Emergency Department. J Thorac Imaging, 37(3), 162-167.
  2. Hendrickson KW, Knox DB, Bledsoe JR, Peltan ID, Jacobs JR, Lloyd JF, Dean NC, Woller SC, Brown SM (2022). Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection vs. Community-acquired Pneumonia. Ann Am Thorac Soc, 19, 1233-1235.
  3. Jones BE, Ying J, Nevers MR, Alba PR, Patterson OV, Peterson KS, Rutter E, Christensen MA, Stern S, Jones MM, Gundlapalli A, Dean NC, Samore MC, Greene T (2022). Trends in Illness Severity, Hospitalization, and Mortality for Community-Onset Pneumonia at 118 US Veterans Affairs Medical Centers. J Gen Intern Med.
  4. Dean NC, Vines CG, Carr JR, Rubin JG, Webb BJ, Jacobs JR, Butler AM, Lee J, Jephson AR, Jenson N, Walker M, Brown SM, Irvin JA, Lungren MP, Allen TL (2022). A Pragmatic Stepped-wedge, Cluster-controlled Trial of Real-time Pneumonia Clinical Decision Support. Am J Respir Crit Care Med, 205, 1330-1336.
  5. Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC (2019). Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J, 54(1).
  6. Webb BJ, Sorensen J, Mecham I, Buckel W, Ooi L, Jephson A, Dean NC (2019). Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia. Chest, 156, 843-851.
  7. Neill S, Dean N (2019). Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung. Curr Opin Infect Dis, 32(2), 152-157.
  8. Goyal D, Dean N, Neill S, Jones P, Dascomb K (2019). Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections-A Retrospective Study of Symptomatic Urinary Tract Infections. Open Forum Infect Dis, 6(2), ofy357.
  9. Jones BE, Collingridge DS, Vines CG, Post H, Holmen J, Allen TL, Haug P, Weir CR, Dean NC (2019). CDS in a Learning Health Care System: Identifying Physicians' Reasons for Rejection of Best-Practice Recommendations in Pneumonia through Computerized Clinical Decision Support. Appl Clin Inform, 10(1), 1-9.
  10. Berjaoui W, Dean N, Dahle N (2006). Proteinuria, pancytopenia and hypoxaemic respiratory failure in a 28-year-old female. Eur Respir J, 28(2), 452-5.


  1. Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA, Aliberti S, Anzueto A, Arancibia F, Arnold F, Azoulay E, Blasi F, Bordon J, Burdette S, Cao B, Cavallazzi R, Chalmers J, Charles P, Chastre J, Claessens YE, Dean N, Duval X, Fartoukh M, Feldman C, File T, Froes F, Furmanek S, Gnoni M, Lopardo G, Luna C, Maruyama T, Menendez R, Metersky M, Mildvan D, Mortensen E, Niederman MS, Pletz M, Rello J, Restrepo MI, Shindo Y, Torres A, Waterer G, Webb B, Welte T, Witzenrath M, Wunderink R (2020). Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. [Review]. Chest, 158(5), 1896-1911.


  1. Callahan SJ, Harris D, Collingridge DS, Guidry DW, Dean NC, Lanspa MJ, Blagev DP (2020). Diagnosing EVALI in the Time of COVID-19. [Letter to the editor]. Chest, 158(5), 2034-2037.
  2. Hirshberg EL, Lanspa MJ, Brown SM, Dean NC, Grissom CK (2019). The authors reply. [Letter to the editor]. Crit Care Med, 47(8), e724-e726.


  1. Peltan ID, McLean SR, Murnin E, Butler AM, Wilson EL, Samore MH, Hough CL, Dean NC, Bledsoe JR, Brown SM (2022). Prevalence, Characteristics, and Outcomes of Emergency Department Discharge Among Patients With Sepsis. JAMA Netw Open (5(2), pp. e2147882). United States.
  2. Carr JR, Jones BE, Collingridge DS, Webb BJ, Vines C, Zobell B, Allen TL, Srivastava R, Rubin J, Dean NC (2020). Deploying an Electronic Clinical Decision Support Tool for Diagnosis and Treatment of Pneumonia Into Rural and Critical Access Hospitals: Utilization, Effect on Processes of Care, and Clinician Satisfaction. J Rural Health (38(1), pp. 262-269). England.
  3. Jones BE, Ying J, Nevers M, Alba PR, He T, Patterson OV, Jones MM, Stevens V, Shen J, Humpherys J, Peterson KS, Rutter ED, Gundlapalli AV, Weir CR, Dean NC, Fine MJ, Samore MC, Greene TH (2021). Computerized Mortality Prediction for Community-acquired Pneumonia at 117 Veterans Affairs Medical Centers. Ann Am Thorac Soc (18(7), pp. 1175-1184). United States.